Patent granted for Dendritic Nanogel carriers (DNG) in the US

The DNG platform is an innovative nanocarrier platform based on dendritic materials, with the potential to encapsulate, transport, and control the release of cargo (e.g., pharmaceuticals, peptides, and antibiotics). DNG is Polymer Factory’s alternative carrier to already established liposome carriers.

CEO Elin Mignérus:
"A strong patent protection is valuable both for Polymer Factory and for potential future partners. Our main commercial focus is on Europe and the USA, why this decision from the USPTO is an important step forward in our journey to commercialize the DNG platform"

The filing date for the patent application is August 13, 2019, and it is granted for 20 years from the validity date, which provides market exclusivity during this period. Polymer Factory has filed corresponding patent applications in other geographies.

Datum 2024-07-03, kl 10:43
Källa Cision
Bifogade filer
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet